Morgan Stanley Downgrades Tandem Diabetes Care (NASDAQ:TNDM) to Equal Weight
Tandem Diabetes Care (NASDAQ:TNDM – Get Free Report) was downgraded by Morgan Stanley from an “overweight” rating to an “equal weight” rating in a research report issued to clients and investors on Wednesday, Marketbeat Ratings reports. They presently have a $22.00 price target on the medical device company’s stock, down from their prior price target […]
Tandem Diabetes Care (NASDAQ:TNDM – Get Free Report) was downgraded by Morgan Stanley from an “overweight” rating to an “equal weight” rating in a research report issued to clients and investors on Wednesday, Marketbeat Ratings reports. They presently have a $22.00 price target on the medical device company’s stock, down from their prior price target […]
